Sagittarius Life Science Corp (TPEX:3205)

Sagittarius Life Science Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,499	1,040	1,699	1,325	895	1,113
Market Cap Growth	191.35%	-38.79%	28.26%	48.00%	-19.59%	-34.43%
Enterprise Value	2,696	890	1,480	1,137	612	731
Last Close Price	51.80	31.95	52.20	40.70	27.50	34.20
PS Ratio	7.84	2.22	3.86	2.50	1.52	1.99
PB Ratio	3.31	2.48	3.22	2.91	1.68	1.89
P/TBV Ratio	3.32	2.55	3.30	3.00	1.73	1.90
EV/Sales Ratio	6.05	1.90	3.36	2.15	1.04	1.31
EV/FCF Ratio	-64.56	-	-	-	-	-
Debt / Equity Ratio	0.01	0.03	0.03	0.03	0.05	0.06
Asset Turnover	0.50	0.79	0.71	0.84	0.83	0.72
Inventory Turnover	14.53	12.35	12.41	15.80	15.85	15.95
Quick Ratio	10.47	2.31	2.09	2.72	3.24	3.68
Current Ratio	10.89	2.73	2.62	3.22	3.56	4.03
Return on Equity (ROE)	-6.83%	-10.50%	-11.57%	-15.50%	-15.62%	-11.80%
Return on Assets (ROA)	-4.07%	-6.50%	-6.47%	-8.19%	-7.94%	-5.78%
Return on Capital (ROIC)	-4.53%	-7.93%	-7.99%	-10.05%	-9.52%	-6.73%
Earnings Yield	-1.55%	-4.67%	-3.24%	-5.60%	-9.66%	-6.66%
FCF Yield	-1.19%	-4.59%	-4.20%	-4.08%	-4.18%	-6.57%
Buyback Yield / Dilution	-11.88%	-	-	-	0.22%	0.47%
Total Shareholder Return	-	-	-	-	0.22%	0.47%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.